Tilfrinib blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases.
Molecular Weight
275.31
Molecular Formula
C17H13N3O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tilfrinib is studied for its ability to inhibit Src kinase, which is crucial for understanding Src-related pathways in cancer research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
